Prasad Priya
Prasad Priya, CC, reported a transaction classified as grant at Syra Health Corp involving 60687.000000 shares for an estimated $0.00. Reported holdings after the transaction were 60687.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 31, 2026
- Filing date
- Sep 02, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
SYRA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001493152-26-041251 Stock Options
- Transaction date
- Aug 31, 2026 Filed Sep 02, 2026, 09:00 PM · 2d delay
- Shares
- 60,687 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 60,687 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
COO and CFO
- F1
20% of the Performance Stock Units vest each year after date of grant subject to the achievement of certain company financial metrics.
- F2
20% of the options vest on each of December 31, 2027, 2028, 2029, 2030 and 2031.
- F3
20% of the restricted stock units vest on each of December 31, 2027, 2028, 2029, 2030 and 2031
0 other transactions
0 recent txs